HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aijiang Nuerlan Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

2/2020TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
9/2019Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aijiang Nuerlan Research Topics

Disease

2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2020 - 09/2019
1Neoplasms (Cancer)
09/2019
1Lymphoma (Lymphomas)
09/2019

Drug/Important Bio-Agent (IBA)

1ELAV-Like Protein 2IBA
02/2020
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
02/2020
1Proteins (Proteins, Gene)FDA Link
09/2019

Therapy/Procedure

1Therapeutics
09/2019
1Aftercare (After-Treatment)
09/2019